zzlangerhans’ Activity

Thu Feb 4

CAPS Underperform Pitch

zzlangerhans wrote about CONATUS PHARMACEUTICALS INC (CNAT) . 9:13 AM

CNAT Underperform

Over the last couple of years one of the most reliable trades in pharma has been shorting spikes after announcements of Fast Track Designation. For more on the details of this program see the description here [more]

Wed Feb 3

CAPS Underperform Pitch

zzlangerhans wrote about ATHERSYS, INC. (ATHX) . 3:56 PM

ATHX Underperform

Nothing new from my last red thumb except an inexplicable price rebound despite a crashing sector, so I'll repost my last pitch. I just wasted close to an hour trying to translate pages of handwaving from the last Athersys conference call into [more]

Caps Pick

zzlangerhans made a pick in CAPS. 12:31 PM

ATHERSYS, INC. (ATHX) will Underperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 12:30 PM

ANAVEX LIFE SCIENCES (AVXL) will Underperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 12:30 PM

CLOVIS ONCOLOGY INC (CLVS) will Outperform the S&P 500

Caps Pick

zzlangerhans made a pick in CAPS. 11:08 AM

CONATUS PHARMACEUTICALS INC (CNAT) will Underperform the S&P 500

Sat Jan 30

CAPS Underperform Pitch

zzlangerhans wrote about La Jolla Pharmaceutical Company (LJPC) . 4:41 PM

LJPC Underperform

It's nice to close a winning pick once in a while, and the best way to do that these days is to red thumb bios on the rebound. Of course, I don't have a lot of options for that because I've already got underwater green thumbs on most bios I follow. [more]

Thu Jan 28

CAPS Underperform Pitch

zzlangerhans wrote about Discovery Laboratories, Inc. (DSCO) . 1:04 PM

DSCO Underperform

Discovery Labs is one of those companies that seemed to have a lock on a new therapy so golden they couldn't fail. A surfactant analogue to prevent lung damage in premature babies? Sign me up. That was before multiple failure to get Surfaxin [more]

Caps Pick

zzlangerhans made a pick in CAPS. 11:27 AM

La Jolla Pharmaceutical Company (LJPC) will Underperform the S&P 500

Wed Jan 27

Caps Pick

zzlangerhans made a pick in CAPS. 2:58 PM

Discovery Laboratories, Inc. (DSCO) will Underperform the S&P 500

Sun Jan 24

CAPS Outperform Pitch

zzlangerhans wrote about Alcobra Pharmaceuticals (ADHD) . 9:08 PM

ADHD Outperform

The strangest thing about Alcobra is the resilience in the share price despite the questionable provenance of the company and failure after failure in clinical trials. After losing my entire stake on puts despite correctly predicting the most recent [more]

Caps Pick

zzlangerhans made a pick in CAPS. 9:08 PM

Alcobra Pharmaceuticals (ADHD) will Outperform the S&P 500

CAPS Underperform Pitch

zzlangerhans wrote about AQUINOX PHARMACEUT (AQXP) . 8:36 PM

AQXP Underperform

Aquinox is rebounding nicely from the lows, thanks to an increasing Baker Bros stake, but I'm still going to hold onto my long-term theory that the company is worthless. AQX-1125 has unequivocally failed for two indications and showed a non-stat sig [more]

Wed Jan 20

Caps Pick

zzlangerhans made a pick in CAPS. 3:38 PM

AQUINOX PHARMACEUT (AQXP) will Underperform the S&P 500

Fri Jan 15

CAPS Outperform Pitch

zzlangerhans wrote about Verastem, Inc. (VSTM) . 10:32 AM

VSTM Outperform

I closed my prior futile green thumb on Verastem and immediately opened a new one, since in CAPS it pays to have a lower starting price if one is right long-term about a stock. If the stock doubles from here, I get an accuracy and 100 points, whereas [more]

Thu Jan 14

Caps Pick

zzlangerhans made a pick in CAPS. 11:31 AM

Verastem, Inc. (VSTM) will Outperform the S&P 500

Wed Jan 13

CAPS Outperform Pitch

zzlangerhans wrote about NEOTHETICS INC COM (NEOT) . 12:41 PM

NEOT Outperform

Neothetics failed in phase III, crushing the hopes of retail cultists and validating the use of the institutional ownership parameter to evaluate apparently cheap stocks with an upcoming binary catalyst. The stock is now a different animal of course, [more]

Caps Pick

zzlangerhans made a pick in CAPS. 11:38 AM

NEOTHETICS INC COM (NEOT) will Outperform the S&P 500

Tue Jan 12

CAPS Outperform Pitch

zzlangerhans wrote about Intra-Cellular Therapies Inc. (ITCI) . 1:29 AM

ITCI Outperform

I like Intra-Cellular's position despite the recent massive pullback. After strong enough phase III data from the first schizophrenia trial to support FDA approval, data from the second phase III trial is expected in mid 2016. The company has also [more]

CAPS Outperform Pitch

zzlangerhans wrote about GlobeImmune, Inc. (GBIM) . 12:35 AM

GBIM Outperform

I have to admit I'm a little confused by the recent excitement about GlobeImmune as a buyout candidate but I'm dropping a green thumb on this retrace just in case I missed something. The stock dropped as low as 2.1 in November, where I would have [more]

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.80
Player Rank 152 out of 74891
Score 5850.48
Score Change Today +182.78
Accuracy 81.80%
Active Picks 155
Total Picks 2165
Best Pick BDSI (+1070.42)
Worst Pick PCYC.DL (-2886.09)
Average Score per Pick 2.70
Charms Earned 16
Highest Rated Favorite pavlos1971
Go to zzlangerhans’ CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show zzlangerhans’ 10 Latest Posts